Table IV.
Univariate analysis of individual parameters correlated with the median overall survival (mOS) of patients with glioma.
| Variable | n | mOS (months) | P-value |
|---|---|---|---|
| Gender | |||
| Male/female | 40/52 | 25.5/22.4 | 0.10 |
| Age | |||
| >35/≤35 years | 56/36 | 24.321/22.833 | 0.32 |
| Histological classification | |||
| Astrocytomas/oligodendrogliomas/GBM | 42/25/25 | 27.8/25.2/15.480 | <0.01 |
| Pathological grade | |||
| I–II/III–IV | 42/50 | 28.5/19.7 | <0.01 |
| Tumor size | |||
| ≥5 cm/<5 cm | 47/45 | 23.5/24.0 | 0.48 |
| TIP30 expression | |||
| Positive/negative | 50/42 | 26.4/20.6 | 0.02 |
| EGFR expression | |||
| Positive/negative | 53/39 | 21.3/27.0 | 0.02 |
TIP30, Tat-interacting protein 30, EGFR, epidermal growth factor receptor; GBM, glioblastoma multiforme.